Utility of serum β2‐microglobulin for prediction of kidney outcome among patients with biopsy‐proven diabetic nephropathy
- 3 November 2023
- journal article
- research article
- Published by Wiley in Diabetes, Obesity and Metabolism
- Vol. 26 (2) , 583-591
Abstract
Aim: To examine whether serum β2‐microglobulin (β2‐MG) could improve the prediction performance for kidney failure with replacement therapy (KFRT) among patients with diabetic nephropathy (DN). Methods: Patients with biopsy‐proven DN at Nara Medical University Hospital were included. The exposure of interest was log‐transformed serum β2‐MG levels measured at kidney biopsy. The outcome variable was KFRT. Multivariable Cox regression models and competing‐risk regression models, with all‐cause mortality as a competing event, were performed. Model fit by adding serum β2‐MG levels was calculated using the Akaike information criterion (AIC). The net reclassification improvement (NRI) and integrated discrimination improvement (IDI) indexes were used to evaluate the improvement of predictive performance for 5‐year cumulative incidence of KFRT by serum β2‐MG levels. Results: Among 408 patients, 99 developed KFRT during a median follow‐up period of 6.7 years. A higher serum β2‐MG level (1‐unit increase in log‐transformed serum β2‐MG level) was associated with a higher incidence of KFRT, even after adjustments for previously known clinical and histological risk factors (hazard ratio [95% confidence interval {CI}]: 3.30 [1.57‐6.94] and subdistribution hazard ratio [95% CI]: 3.07 [1.55‐6.06]). The addition of log‐transformed serum β2‐MG level reduced AIC and improved the prediction of KFRT (NRI and IDI: 0.32 [0.09‐0.54] and 0.03 [0.01‐0.56], respectively). Conclusions: Among patients with biopsy‐proven DN, serum β2‐MG was an independent predictor of KFRT and improved prediction performance. In addition to serum creatinine, serum β2‐MG should probably be measured for DN.Keywords
Funding Information
- Japan Society for the Promotion of Science (18K15984)
This publication has 51 references indexed in Scilit:
- Evaluation and Management of Chronic Kidney Disease: Synopsis of the Kidney Disease: Improving Global Outcomes 2012 Clinical Practice GuidelineAnnals of Internal Medicine, 2013
- Plasma beta-2 microglobulin is associated with cardiovascular disease in uremic patientsKidney International, 2012
- Circulating TNF Receptors 1 and 2 Predict ESRD in Type 2 DiabetesJournal of the American Society of Nephrology, 2012
- Revised Equations for Estimated GFR From Serum Creatinine in JapanAmerican Journal of Kidney Diseases, 2009
- Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 DiabetesNew England Journal of Medicine, 2008
- Influence of Muscle Mass and Physical Activity on Serum and Urinary Creatinine and Serum Cystatin CClinical Journal of the American Society of Nephrology, 2008
- Podocytes use FcRn to clear IgG from the glomerular basement membraneProceedings of the National Academy of Sciences, 2008
- Cystatin C and beta2-microglobulin: markers of glomerular filtration in critically ill childrenCritical Care, 2007
- Timed Urine Collections Are Not Needed to Measure Urine Protein Excretion in Clinical PracticeAmerican Journal of Kidney Diseases, 2006
- Predictors of New-Onset Kidney Disease in a Community-Based PopulationJAMA, 2004